ARROWHEAD PHARMACEUTICALS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 25 USD | -0.16% |
|
+1.13% | -18.30% |
| 10/05 | UBS Cuts Price Target on Arrowhead Pharmaceuticals to $71 From $75, Keeps Buy Rating | MT |
| 09/05 | Arrowhead Pharmaceuticals Swings to Loss in Fiscal Q2 | MT |
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. | Bio Therapeutic Drugs | -0.16% | +1.13% | -18.30% | -33.58% | +28.40% | 3.11B |  | |  |
- Stock Market
- Equities
- ARWR Stock
- Charts Arrowhead Pharmaceuticals, Inc.
- Relative Strength Chart